Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer’s disease: a longitudinal cohort study

Blood biomarkers have great potential to advance clinical care and accelerate trials in Alzheimer’s disease (AD). Plasma phospho-tau181 (p-tau181) is a promising blood biomarker however, it is unknown if levels increase in presymptomatic AD. Therefore, we investigated the timing of p-tau181 changes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Psychiatry
Autors principals: O’Connor, Antoinette, Karikari, Thomas K, Poole, Teresa, Ashton, Nicholas J., Rodriguez, Juan Lantero, Khatun, Ayesha, Swift, Imogen, Heslegrave, Amanda J, Abel, Emily, Chung, Elisha, Weston, Philip SJ, Pavisic, Ivanna M, Ryan, Natalie S, Barker, Suzie, Rossor, Martin N, Polke, James M, Frost, Chris, Mead, Simon, Blennow, Kaj, Zetterberg, Henrik, Fox, Nick C
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7612227/
https://ncbi.nlm.nih.gov/pubmed/32665603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41380-020-0838-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars